Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives

Igor A. Schepetkin, Andrey Ivanovich Khlebnikov, Liliya N. Kirpotina, Mark T. Quinn

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.

Original languageEnglish
Pages (from-to)43-58
Number of pages16
JournalInternational Immunopharmacology
Volume37
DOIs
Publication statusPublished - 1 Aug 2016
Externally publishedYes

Fingerprint

Formyl Peptide Receptor
Biological Products
Neutrophils
HL-60 Cells
human FPR1 protein
Ligands
Inflammation

Keywords

  • Ca flux
  • Formyl peptide receptor 1
  • Molecular modeling
  • Natural compound
  • Neutrophil
  • Neutrophil elastase
  • Receptor antagonist
  • Superoxide anion radical

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Pharmacology

Cite this

Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives. / Schepetkin, Igor A.; Khlebnikov, Andrey Ivanovich; Kirpotina, Liliya N.; Quinn, Mark T.

In: International Immunopharmacology, Vol. 37, 01.08.2016, p. 43-58.

Research output: Contribution to journalArticle

@article{95a36ab7fb434081b7e8ff19199f7c40,
title = "Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives",
abstract = "Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.",
keywords = "Ca flux, Formyl peptide receptor 1, Molecular modeling, Natural compound, Neutrophil, Neutrophil elastase, Receptor antagonist, Superoxide anion radical",
author = "Schepetkin, {Igor A.} and Khlebnikov, {Andrey Ivanovich} and Kirpotina, {Liliya N.} and Quinn, {Mark T.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1016/j.intimp.2015.08.036",
language = "English",
volume = "37",
pages = "43--58",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",

}

TY - JOUR

T1 - Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives

AU - Schepetkin, Igor A.

AU - Khlebnikov, Andrey Ivanovich

AU - Kirpotina, Liliya N.

AU - Quinn, Mark T.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.

AB - Formyl peptide receptor 1 (FPR1) regulates a wide variety of neutrophil functional responses and plays an important role in inflammation and the pathogenesis of various diseases. To date, a variety of natural and synthetic molecules have been identified as FPR1 ligands. Here, we review current knowledge on natural products and natural product-inspired small molecules reported to antagonize and/or inhibit the FPR1-mediated responses. Based on this literature, additional screening of selected commercially available natural compounds for their ability to inhibit fMLF-induced Ca2 + mobilization in human neutrophils and FPR1 transfected HL-60 cells, and pharmacophore modeling, natural products with potential as FPR1 antagonists are considered and discussed in this review. The identification and characterization of natural products that antagonize FPR1 activity may have potential for the development of novel therapeutics to limit or alter the outcome of inflammatory processes.

KW - Ca flux

KW - Formyl peptide receptor 1

KW - Molecular modeling

KW - Natural compound

KW - Neutrophil

KW - Neutrophil elastase

KW - Receptor antagonist

KW - Superoxide anion radical

UR - http://www.scopus.com/inward/record.url?scp=84941695973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941695973&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2015.08.036

DO - 10.1016/j.intimp.2015.08.036

M3 - Article

VL - 37

SP - 43

EP - 58

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

ER -